Go Pro
TSE:ACB

Aurora Cannabis Q2 2025 Earnings Report

Aurora Cannabis logo
C$5.04 -0.23 (-4.36%)
As of 12:58 PM Eastern

Aurora Cannabis EPS Results

Actual EPS
C$0.05
Consensus EPS
-C$0.30
Beat/Miss
Beat by +C$0.35
One Year Ago EPS
-C$0.70

Aurora Cannabis Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Aurora Cannabis Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Aurora Cannabis Earnings Headlines

Are you signed up for this 4x text message?
Since 2003, one private alert service has sent over 14,000 buy signals averaging 310% gains each - including the underperformers. Past picks include Butler National Corporation up 564%, D-Box Technologies up 610%, and Limbach Holdings up 790%. The same service predicted nearly every major financial crisis of the past century and called the collapse of 99.8% of banks that failed during the Great Financial Crisis. The next alert could arrive as early as 9:30 tomorrow morning.tc pixel
See More Aurora Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aurora Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aurora Cannabis and other key companies, straight to your email.

About Aurora Cannabis

Aurora Cannabis (TSE:ACB), headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

View Aurora Cannabis Profile